Book Review PARKINSON'S DISEASE: MEDICATIONS by Jean Pinter Hubble and Richard C. Berchou (NPF: 1999) 80 pps. Don't be fooled by the pamphlet-like format of this little treasure-trove of information. Written by an M.D. and a Pharm. D., this collection of 8 ½ by 11 inch pages is every bit the equivalent of a book and will take more than one sitting to read. The text consists of nine chapters and six appendices. Though the format works well with forms, such as the medications chart and Patient Diary, included in appendix; it is not easier for those with dexterity problems to handle. Also some of the decorative cartoon color illustrations provided by Athena detract from the quality of the content of the text. Each chapter focuses on an area of treatment beginning with Phamacotherapy. The layperson who hasn't memorized drug classifications may have to backtrack from some of the later chapters to know just which pills were dopaminergic and which antidepressants were tricyclic. But that's no problem -- each chapter is clearly written and well organized using easy-to-find lists and red headings. Thumbing through the pages is no problem (unless your lap is smaller than a foot square.) Other chapter topics include neuroprotection, mood and cognition, sleep disorders, new drugs, even a brief discussion of alternative medicine. Appendices include contraindicated drugs, a formula for liquid sinemet and patient care planning tools. Written in a reader-friendly style, this book seems to hold the answers to all those questions we forgot to ask and that our doctors might not have time to answer. Get a copy of this book free from NPF, ASAP (As Soon As Possible -- sorry, I couldn't resist). Get a copy for your doctors, your families, and your friends too!. You're not going to want to give your copy away - it is too valuable as a reference tool for now and in the future. The author of this review has an MLS from Clarion University and was diagnosed PWP in 1991 at age 40. She wishes to express deepest gratitude to the authors, and be first in line for the new SIB-1508 mentioned (p.57) when it's approved.